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AbsTrACT
Objective To investigate whether people with more 
positive attitudes to ageing are biologically younger 
as defined by leucocyte telomere length, accelerated 
DNA methylation GrimAge (AgeAccelGrim) and brain- 
predicted age difference, and whether these biomarkers 
explain relationships between attitudes to ageing and 
mortality.
Methods We used linear regression to examine 
cross- sectionally attitudes to ageing (measured using 
the Attitudes to Ageing Questionnaire) and the three 
biomarkers in 758 adults, mean age 72.5 years, from the 
Lothian Birth Cohort 1936. We used Cox proportional 
hazards models to examine longitudinally attitudes to 
ageing and mortality and the role of the biomarkers.
results More positive attitude to physical change was 
associated with younger biological age, as measured 
by AgeAccelGrim and brain- predicted age difference 
in age- adjusted and sex- adjusted models: for an SD 
higher score, AgeAccelGrim was lower by -0.73 (95% 
CI -1.03 to -0.42) of a year, and brain- predicted age 
difference was lower by -0.87 (1.51 to 0.23) of a year. 
Both associations were attenuated by adjustment 
for covariates and not significant after simultaneous 
adjustment for all covariates and correction for multiple 
testing. More positive attitudes to physical change were 
associated with lower mortality: for an SD higher score 
the age- adjusted and sex- adjusted HR (95% CI) was 0.66 
(0.56 to 0.78). Adjustment for AgeAccelGrim or brain- 
predicted age difference attenuated this association 
slightly. It remained significant after adjustment for all 
covariates.
Conclusion We found partial evidence that attitudes 
to ageing are linked with ageing biomarkers but they 
accounted for only a little of the association between 
attitudes and mortality.
InTrOduCTIOn
The rapid rate of population ageing has motivated 
research into influences on health and longevity of 
older people. Attitudes to ageing, which encompass 
personal experiences of growing old and general 
beliefs about ageing,1 is one such factor. Levy 
hypothesises that older people internalise cultural 
age stereotypes—which often associate ageing with 
physical decline, disability and loneliness—such 
that they become a self- fulfilling prophecy.2 Having 
more negative perceptions of ageing has been asso-
ciated with a range of adverse health outcomes.3–7 
A meta- analysis found that having a younger subjec-
tive age is associated with better health outcomes 
and a longer life.8 Negative perceptions of ageing 
have been linked with higher mortality.9–11
The underlying mechanisms are poorly under-
stood, but cardiovascular stress,12 cortisol levels,13 
inflammatory biomarkers14 and health behaviours 
may play a role. In 335 older adults, those with 
negative views of ageing had a shorter telomere 
length 4 years later than those with positive atti-
tudes.15 Age- related structural brain changes are 
also more advanced in people with an older subjec-
tive age.16 These findings suggest that attitudes to 
ageing may be associated with cellular and brain 
ageing.
Telomere length, DNA methylation age and 
brain- predicted age difference (brain- PAD) are 
biomarkers of ageing.17 Leucocyte telomere length 
decreases each time a cell replicates and has thus 
been considered a marker of cellular ageing. DNA 
methylation occurs throughout the genome at 
cytosine- phosphate- guanine (CpG) sites to regu-
late gene expression. Methylation patterns give an 
accurate prediction of chronological age which can 
be used to calculate a novel measure of biological 
ageing known as ‘accelerated DNA methylation 
GrimAge’ (AgeAccelGrim),18 which was trained to 
predict survival. Brain- PAD is derived from brain 
MRI scan data. Structural brain changes can be 
identified, which suggest whether an individual’s 
‘brain age’ is younger or older than their actual 
age.17 All three biomarkers are independent predic-
tors of mortality,19 20 and given that attitudes to 
ageing are associated with telomere length15 and 
subjective age is associated with brain- PAD,16 they 
may help explain the relationship between attitudes 
to ageing and mortality in older people.
We investigated whether people with more posi-
tive attitudes to ageing are biologically younger as 
defined by leucocyte telomere length, AgeAccel-
Grim and brain- PAD, and examined the extent to 
which any relationship between attitudes to ageing 
and mortality might be explained by the ageing 
biomarkers.
MeThOds
Participants
The Lothian Birth Cohort 1936 (LBC1936) consists 
of surviving participants of the 1947 Scottish Mental 
Survey recruited to investigate healthy ageing.21 22 
At wave 1, 1091 people (mean age 70 years) were 
recruited. This study uses data from wave 2 (mean 
age 72.5, range 70.9–73.4) and mortality data from 
date of the wave 2 assessment to April 2018.22 
Participants gave written informed consent.
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Figure 1 Sample sizes at waves 1 and 2. Brain- PAD, brain- predicted 
age difference.
Measures
Attitudes to ageing
Participants completed the ‘Attitudes to Ageing Question-
naire’ (AAQ)1 by post at about the same time as wave 2 clinic 
testing. It consists of 24 items scored on a 5- point Likert scale 
which capture general attitudes towards the ageing process and 
personal experience of ageing.1 Scores are calculated under three 
domains: physical change, psychosocial loss and psychological 
growth. Examples of items in each domain include: “my health 
is better than I expected for my age”, ‘old age is a time of lone-
liness’ and ‘wisdom comes with age’. More positive attitudes to 
ageing are indicated by higher scores for physical change and 
psychological growth, and lower scores for psychosocial loss.
Biomarkers of ageing
Leucocyte telomere length
Leucocyte telomere length was measured from DNA extracted 
from whole blood samples at wave 223 followed by quantitative 
PCR, using an Applied Biosystems (Pleasonton, California, USA) 
7900HT Fast Real- Time PCR machine. Four internal control 
DNA samples were run within each plate to correct for plate- 
to- plate variation.
Epigenetic age acceleration
Illumina HumanMethylation 450 BeadChips were used to 
measure DNA methylation from blood samples at wave 2. 
DNA methylation occurs throughout the genome at CpG sites 
to regulate gene expression. Methylation patterns give an accu-
rate prediction of chronological age.24 25 There are several DNA 
methylation- based biomarkers which are used to measure epigen-
etic age or epigenetic age acceleration, known as the ‘epigen-
etic clock’, one of which is ‘DNA methylation GrimAge’.18 
This is a novel epigenetic clock which combines age, sex, DNA 
methylation- based surrogates for smoking and the levels of seven 
serum proteins.26 As is the case with other epigenetic clocks, the 
difference between DNA methylation GrimAge and chronolog-
ical age—accelerated DNA methylation GrimAge (AgeAccel-
Grim)—provides a measure of biological ageing. This variable 
was derived by taking residuals from a linear regression model 
of DNA methylation GrimAge on chronological age. Details of 
how these data were collected and measured have been reported 
previously.26–28
Brain-predicted age difference
T1- weighted structural MRI scans at wave 2 were used to identify 
voxel- wise patterns of brain volume which indicate the degree 
of brain ageing29 and thus inform the calculation of ‘brain- 
predicted age’,17 by reference to a regression model defined in 
an independent sample of healthy individuals (n=2001, aged 
18–90 years).30 Brain- PAD was calculated by subtracting actual 
age from ‘brain- predicted age’.17
Information on the variability of the biomarkers of ageing is 
provided in the online supplementary file 1.
MOrTAlITy
National Records of Scotland provided mortality data for the 
LBC1936 participants via data linkage with the National Health 
Service Central Register.
COvArIATes
At wave 2, symptoms of depression and anxiety were measured 
using the Hospital Anxiety and Depression Scale.31 Partici-
pants were asked if they had been diagnosed with hypertension, 
cardiovascular disease, stroke, diabetes, cancer and arthritis 
and responses were combined to give a total number of chronic 
illnesses. Other covariates were number of years spent in full- 
time education, social class, smoking status, number of days 
alcohol is consumed per week and time taken to walk 6 metres.
sTATIsTICAl AnAlysIs
We used rank- order correlations to examine bivariate associa-
tions between leucocyte telomere length, AgeAccelGrim and 
brain- PAD and other characteristics. Point biserial correlations 
were used for characteristics which were binary variables.
Linear regression was used to examine cross- sectional rela-
tionships between each domain of attitudes to ageing and each 
ageing biomarker, adjusting for age and sex and then further 
adjusting for other covariates. AAQ scores were standardised 
to mean 0 and SD 1 in order to facilitate comparisons. Leuco-
cyte telomere length was log- transformed because it had a 
skewed distribution. All analyses of leucocyte telomere length 
and AgeAccelGrim were adjusted for measured white blood cell 
counts.
Cox proportional hazard regression was used to examine rela-
tionships between each domain of attitudes to ageing and risk of 
death, adjusting for age and sex, further adjusting for the other 
covariates then adding each biomarker of ageing in sequential 
models. Analyses of leucocyte telomere length and AgeAccel-
Grim were also adjusted for white blood cell counts. Survival 
time in days was calculated from date of the wave 2 survey to 
date of death or April 2018, whichever occurred first. Follow- up 
time ranged from 5.4 to 7.9 years (mean=6.8). We tested that 
the proportional hazards assumptions were met using Schoen-
feld residuals.
As we carried out multiple tests of statistical significance, we 
corrected the p values in the multivariable models by applying 
the False Discovery Rate32 across the associations between the 
three ageing biomarkers and the three attitude to ageing domain 
scores and then across the associations between the three atti-
tude to ageing domain scores and mortality.
resulTs
Of the 866 participants in wave 2, 789 (91%) had complete 
data on attitudes to ageing and covariates. Of these 789 partic-
ipants, 758 (96%) had data on leucocyte telomere length, 715 
(91%) had data on AgeAccelGrim and 622 (79%) had data on 
brain- PAD (figure 1). Compared with these 622 participants, 
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Table 1 Characteristics of participants and their rank- order correlations with ageing biomarkers and mortality (n=758)
Characteristics
Mean (sd) or number 
(%)
Correlation with 
leucocyte telomere length
Correlation with 
accelerated dnA 
methylation GrimAge
Correlation with 
brain- PAd
Correlation with death 
during follow- up
n=758 n=715 n=622 n=758
Age in years, mean (SD) 72.5 (0.71) 0.075 (p=0.039) 0.028 (p=0.463) 0.016 (p=0.695) −0.046 (p=0.205)
Female, number (%) 364 (48.0) −0.128 (p=0.004) −0.459 (p<0.001) −0.300 (p<0.001) −0.111 (p=0.002)
Number of years in education, mean (SD) 10.8 (1.14) −0.037 (p=0.312) −0.131 (p=0.001) 0.012 (p=0.770) −0.041 (p=0.268)
Non- manual social class,* number (%) 595 (78.5) 0.027 (p=0.464) 0.185 (p<0.001) 0.035 (p=0.385) 0.139 (p=0.0001)
Number of chronic diseases, mean (SD) 1.55 (1.09) 0.046 (p=0.208) 0.113 (p=0.002) 0.079 (p=0.045) 0.126 (p=0.001)
HADS- A score, mean (SD) 4.49 (3.10) −0.007 (p=0.842) −0.114 (p=0.002) −0.103 (p=0.011) −0.001 (p=0.978)
HADS- D score, mean (SD) 2.51 (2.07) −0.014 (p=0.704) 0.086 (p=0.021) 0.086 (p=0.032) 0.104 (p=0.004)
Smoking status −0.018 (p=0.614) 0.477 (p<0.001) 0.098 (p=0.014) 0.191 (p<0.001)
Never smoked, number (%) 372 (49.1)
Ex- smoker, number (%) 326 (43.0)
Current smoker, number (%) 60 (7.92)
Number of days alcohol is consumed per week, mean (SD) 2.70 (2.68) 0.015 (p=0.672) 0.133 (p=0.004) 0.130 (p=0.001) −0.031 (p=0.397)
Time taken to walk 6 metres, mean (SD) 4.27 (1.10) −0.025 (p=0.486) 0.090 (p=0.016) 0.033 (p=0.407) 0.128 (p=0.004)
Attitudes to ageing
Physical change, mean (SD) 28.0 (5.11) −0.023 (p=0.525) −0.178 (p<0.001) −0.123 (p=0.002) −0.206 (p<0.001)
Psychosocial loss, mean (SD) 15.2 (4.79) 0.003 (p=0.938) 0.085 (p=0.023) 0.012 (p=0.628) 0.126 (p=0.005)
Psychological growth, mean (SD) 28.3 (4.33) −0.005 (p=0.890) −0.033 (p=0.386) −0.023 (p=0.567) −0.067 (p=0.065)
Brain- PAD, mean (SD) 1.38 (8.43) 0.038 (p=0.349) 0.198 (p<0.001) – 0.142 (p=0.001)
Telomere length, mean (SD) 3971.41 (733.0) – 0.046 (p=0.227) 0.038 (p=0.349) 0.0001 (p=0.998)
Accelerated DNA methylation GrimAge, mean (SD) −0.28 (4.75) 0.046 (p=0.227) – 0.198 (p<0.001) 0.209 (p<0.001)
Died during follow- up, number (%) 147 (19.4) 0.0001 (p=0.998) 0.209 (p<0.001) 0.142 (p=0.001) –
*Correlations with social class are based on the six- category occupational social class variable.
Brain- PAD, brain- predicted age difference; DNA, deoxyribonucleic acid 
; HADS- A, Hospital Anxiety and Depression Scale, anxiety score; HADS- D, Hospital Anxiety and Depression Scale, depression score.
the 469 cohort members who were excluded from analyses 
because they did not take part in wave 2 or had missing data 
at wave 2, had spent slightly less time in full- time education, 
were less likely to have a non- manual social class and had 
higher scores for depression and more chronic disease at wave 
1.
Table 1 describes the characteristics of the largest sample 
(n=758) and shows the rank- order correlations between these 
characteristics and the three biomarkers of ageing and death 
during follow- up. In these bivariate analyses, AgeAccelGrim was 
positively associated with being male, less education, lower social 
class, more chronic disease, more symptoms of depression, having 
a history of smoking, drinking alcohol more frequently, slower 
walking speed and having a more negative attitude to physical 
change and to psychosocial loss. AgeAccelGrim was negatively 
associated with symptoms of anxiety. Higher brain- PAD (more 
advanced brain ageing relative to chronological age) was associ-
ated with being male,20 more chronic disease, more symptoms of 
depression, smoking, drinking alcohol more frequently, having a 
more negative attitude to physical change. Higher brain- PAD was 
associated with fewer symptoms of anxiety. Shorter leucocyte 
telomere length was associated with being female and with older 
age, but there were no associations with attitudes to ageing. Of 
the three biomarkers of ageing, AgeAccelGrim and brain- PAD 
were positively correlated (rho=0.198), but neither were asso-
ciated with leucocyte telomere length. Death during follow- up 
was associated with being male, lower social class, more chronic 
disease, greater depression, history of smoking, slower walking 
speed, being biological older as measured by brain- PAD20 and 
AgeAccelGrim,26 and with having more negative attitudes to 
ageing in all three domains.
ATTITudes TO AGeInG And AGeInG bIOMArkers
Table 2 shows the regression coefficients for each ageing 
biomarker according to an SD higher score for each domain 
of the AAQ. Coefficients are shown adjusted first for age and 
sex, then with additional separate adjustment for education 
and social class, smoking and frequency of alcohol consump-
tion, chronic disease and walking speed, anxiety and depression 
symptoms and finally all covariates together. Looking first at 
log leucocyte telomere length, there were no significant associ-
ations between any of the attitude to ageing domain scores and 
this biomarker.
Turning next to AgeAccelGrim, more positive attitudes to 
physical change were associated with being biologically younger 
as measured by this biomarker in the age- adjusted and sex- 
adjusted model: for an SD higher score in attitudes to physical 
change, AgeAccelGrim was lower by 0.725 (95% CI 1.03 to 
0.418) of a year. Adjustment for education and social class or 
anxiety and depression symptoms had only minor effects on this 
association, but it was attenuated by 36% after adjustment for 
smoking and frequency of alcohol consumption, and by 28% 
after adjustment for chronic disease and walking speed, although 
in each case the association remained significant after correction 
for multiple testing. In the final model adjusting for all covari-
ates, the relationship was attenuated by 60%: for an SD higher 
score in attitudes to physical change, AgeAccelGrim was lower 
by 0.289 (95% CI 0.568 to 0.010) of a year. This was not signif-
icant after correction for multiple testing. Having a more posi-
tive attitude to psychosocial loss, as indicated by a lower score 
on this domain, was associated with a slightly lower AgeAccel-
Grim in the age- adjusted and sex- adjusted model, but this was 
not significant after correction for multiple testing. There was 
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Table 2 Regression coefficients (95% CI) of ageing biomarkers according to standardised scores on attitudes to ageing scales at age 72 years
Attitudes to ageing scales, per sd leucocyte telomere length* (n=758) Accelerated dnA methylation GrimAge† (n=715) brain- predicted age difference (n=622)
Physical change
  Adjusted for age and sex −0.003 (−0.009 to 0.003) p=0.272; pFDR=0.637 −0.725 (−1.03 to –0.418) p<0.001; pFDR=0.001 −0.871 (−1.513 to –0.229) p=0.008; pFDR=0.062
  Adjusted for age, sex, education and social class −0.003 (−0.009 to 0.003) p=0.287; pFDR=0.637 −0.689 (−1.00 to –0.380) p<0.001; pFDR=0.001 −0.894 (−1.538 to –0.225) p=0.007; pFDR=0.062
  Adjusted for age, sex, smoking and alcohol −0.004 (−0.009 to 0.002) p=0.220; pFDR=0.625 −0.467 (−0.721 to –0.211) p<0.001; pFDR=0.001 −0.804 (−1.45 to –0.159) p=0.015; pFDR=0.101
  Adjusted for age, sex, chronic disease and walking 
speed
−0.003 (−0.009 to 0.003) p=0.387; pFDR=0.756 −0.520 (−0.842 to –0.197) p=0.002; pFDR=0.021 −0.657 (−1.323 to –0.010) p=0.054; pFDR=0.224
  Adjusted for age, sex, anxiety and depression 
symptoms
−0.004 (−0.001 to 0.003) p=0.255; pFDR=0.637 −0.703 (−1.03 to –0.373) p<0.001; pFDR=0.001 −0.672 (−1.346 to 0.001) p=0.050; pFDR=0.224
  Multivariable- adjusted‡ −0.004 (−0.010 to 0.003) p=0.287; pFDR=0.637 −0.289 (−0.568 to –0.010) p=0.042; pFDR=0.206 −0.456 (−1.15 to 0.240) p=0.199; pFDR=0.625
Psychosocial loss
  Adjusted for age and sex 0.001 (−0.005 to 0.006) p=0.838; pFDR=0.935 0.370 (0.055 to 0.684) p=0.021; pFDR=0.126 0.127 (−0.514 to 0.768) p=0.697; pFDR=0.867
  Adjusted for age, sex, education and social class 0.001 (−0.005 to 0.006) p=0.862; pFDR=0.935 0.335 (0.021 to 0.648) p=0.036; pFDR=0.194 0.156 (−0.488 to 0.801) p=0.634; pFDR=0.867
  Adjusted for age, sex, smoking and alcohol 0.001 (−0.005 to 0.006) p=0.775; pFDR=0.930 0.098 (−0.162 to 0.358) p=0.460; pFDR=0.803 0.059 (−0.588 to 0.705) p=0.858; pFDR=0.934
  Adjusted for age, sex, chronic disease and walking 
speed
0.001 (−0.006 to 0.006) p=0.937; pFDR=0.955 0.215 (−0.101 to 0.531) p=0.181; pFDR=0.611 −0.055 (−0.703 to 0.593) p=0.869; pFDR=0.935
  Adjusted for age, sex, anxiety and depression 
symptoms
0.001 (−0,007 to 0.007) p=0.883; pFDR=0.935 0.325 (−0.039 to 0.689) p=0.080; pFDR=0.309 −0.260 (−0.984 to 0.465) p=0.482; pFDR=0.803
  Multivariable- adjusted‡ 0.001 (−0.006 to 0.007) p=0.876; pFDR=0.935 −0.010 (−0.308 to 0.282) p=0.931; pFDR=0.955 −0.389 (−1.119 to 0.340 p=0.295; pFDR=0.637
Psychological growth
  Adjusted for age and sex −0.001 (−0.007 to 0.004) p=0.642; pFDR=0.868 −0.072 (−0.385 to 0.240) p=0.707; pFDR=0.867 −0.439 (−1.13 to 0.250) p=0.212; pFDR=0.625
  Adjusted for age, sex, education and social class −0.002 (−0.007 to 0.004) p=0.602; pFDR=0.868 −0.129 (−0.441 to 0.182) p=0.417; pFDR=0.776 −0.421 (−1.11 to 0.272) p=0.234; pFDR=0.632
  Adjusted for age, sex, smoking and alcohol −0.002 (−0.008 to 0.004) p=0.491; pFDR=0.803 0.113 (−0.146 to 0.371) p=0.392; pFDR=0.756 −0.352 (−1.05 to 0.343) p=0.320; pFDR=0.665
  Adjusted for age, sex, chronic disease and walking 
speed
−0.001 (−0.007 to 0.004) p=0.678; pFDR=0.868 −0.069 (−0.376 to 0.239) p=0.662; pFDR=0.868 −0.473 (−1.16 to 0.213) p=0.176; pFDR=0.610
  Adjusted for age, sex, anxiety and depression 
symptoms
−0.001 (−0.007 to 0.004) p=0.646; pFDR=0.868 0.003 (−0.317 to 0.323) p=0.986; pFDR=0.986 −0.219 (-0.925, 0.487) p=0.543; pFDR=0.837
  Multivariable- adjusted‡ −0.002 (−0.008 to 0.004) p=0.490; pFDR=0.803 −0.075 (−0.188 to 0.338) p=0.575; pFDR=0.827 −0.191 (-0.906 to 0.525) p=0.601; pFDR=0.868
*All analyses of leucocyte telomere length were also adjusted for white blood cell counts.
†All analyses of accelerated DNA methylation GrimAge were adjusted for white blood cell counts.
‡Adjusted for age, sex, educational attainment, social class, total number of chronic diseases, smoking status, frequency of alcohol consumption, time taken to walk 6 metres, HADS anxiety score, HADS depression score.
§pFDR is the p value corrected for multiple comparisons using the False Discovery Rate.
HADS, Hospital Anxiety and Depression Scale.
no association between attitudes to psychological growth and 
AgeAccelGrim.
Looking finally at brain- PAD, in the age- adjusted and sex- 
adjusted model, an SD higher score for attitudes to physical 
change was associated with a brain- PAD that was lower by 0.871 
(95% CI 1.513 to 0.229) of a year. This ceased to be significant 
after correction for multiple testing. This association was slightly 
strengthened by adjustment for education and social class but 
remained non- significant after correction for multiple testing. 
Adjustment for either chronic disease and walking speed or 
anxiety and depression symptoms had the strongest attenuating 
effects, reducing the association by 25% or 22%, respectively. In 
the final model adjusting for all covariates, the relationship was 
attenuated by 48% and no longer significant: for an SD higher 
score in attitudes to physical change, brain- PAD was lower by 
0.456 (95% CI −1.15 to 0.240) of a year. Attitudes to psycho-
social loss and psychological growth were not significantly asso-
ciated with brain- PAD.
ATTITudes TO AGeInG And MOrTAlITy
Tables 3 and 4 show the HRs (95% CI) for death during the 
follow- up period according to attitudes to ageing. Estimates are 
shown adjusted first for age and sex, then for AgeAccelGrim 
(table 3) or brain- PAD (table 4), then for education and social 
class, smoking and frequency of alcohol consumption, chronic 
disease and walking speed and anxiety and depression symptoms, 
separately and finally all together. In order to see the extent to 
which any effect of either AgeAccelGrim or brain- PAD on the 
relationships between attitudes to ageing and mortality might be 
explained by the covariates, we also show the HRs adjusted for 
each type of covariate plus either AgeAccelGrim or brain- PAD. 
We have not included a similar table showing estimates adjusted 
for leucocyte telomere length as this was not associated with 
mortality or attitudes to ageing in this sample (tables 1 and 2).
In participants with data on AgeAccelGrim (table 3), partic-
ipants with a more positive attitude to physical change had a 
markedly lower risk of mortality after adjusting for age and 
sex: for an SD higher score, the HR (95% CI) was 0.66 (0.56 
to 0.78); this remained significant after correction for multiple 
testing. Adjustment for AgeAccelGrim attenuated this by 14.7%. 
Adjustment for each type of covariate in turn had minor atten-
uating effects on the age- adjusted and sex- adjusted effect size. 
When AgeAccelGrim was added to each of these models it had 
small attenuating effects, suggesting its effect is not explained 
entirely by these covariates. After full adjustment for AgeAccel-
Grim and all other covariates, having a more positive attitude to 
physical change remained associated with lower mortality after 
correction for multiple testing: for an SD higher score, the HR 
(95% CI) was 0.76 (0.64 to 0.91). Having a more positive atti-
tude to psychosocial loss (indicated by lower scores) was also 
associated with lower mortality in age- adjusted and sex- adjusted 
models: for an SD higher score, the HR was 1.28 (1.09 to 1.50); 
this was significant after correction of multiple testing. This was 
attenuated by 17.9% by adjustment for AgeAccelGrim. Adjust-
ment for each type of covariate in turn had some attenuating 
effects on the age- adjusted and sex- adjusted effect size, with 
chronic disease and walking speed having the strongest effect, 
weakening the association by 35.7%. After full adjustment for 
AgeAccelGrim and all covariates, the association was attenuated 
by 46.4% and was not significant. People with a more positive 
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Table 3 HRs (95% CI) of death from all causes according to standardised scores on attitudes to ageing scales at age 72 years, adjusted for 
accelerated DNA methylation GrimAge (AgeAccelGrim) and covariates (N=715)
Adjustments Physical change †p/pFdr Psychosocial loss †p/pFdr Psychological growth †p/pFdr
Age and sex 0.66 (0.56 to 0.78) <0.001/0.0003 1.28 (1.09 to 1.50) 0.002/0.004 0.87 (0.74 to 1.02) 0.089/0.120
Age, sex and AgeAccelGrim 0.71 (0.61 to 0.84) <0.001/0.0003 1.23 (1.05 to 1.44) 0.0011/0.020 0.89 (0.75 to 1.03) 0.110/0.140
Age, sex, education and social class 0.67 (0.57 to 0.79) <0.001/0.0003 1.25 (1.07 to 1.47) 0.005/0.009 0.84 (0.72 to 0.99) 0.040/0.064
Age, sex, education and social class 
plus AgeAccelGrim
0.72 (0.62 to 0.85) <0.001/0.0003 1.21 (1.03 to 1.42) 0.020/0.033 0.86 (0.73 to 1.01) 0.065/0.097
Age, sex, smoking and alcohol 0.69 (0.58 to 0.81) <0.001/0.0003 1.23 (1.05 to 1.44) 0.011/0.020 0.87 (0.74 to 1.02) 0.088/0.119
Age, sex, smoking and alcohol plus 
AgeAccelGrim
0.71 (0.60 to 0.83) <0.001/0.0003 1.22 (1.04 to 1.42) 0.016/0.029 0.86 (0.75 to 1.01) 0.068/0.100
Age, sex, chronic disease and 
walking speed
0.73 (0.61 to 0.86) <0.001/.0003 1.18 (1.01 to 1.39) 0.043/0.067 0.87 (0.75 to 1.02) 0.092/0.121
Age, sex, chronic disease plus 
AgeAccelGrim
0.76 (0.64 to 0.91) 0.001/0.002 1.16 (0.99 to 1.37) 0.075/0.106 0.88 (0.76 to 1.04) 0.138/0.168
Age, sex, anxiety and depression 0.67 (0.56 0.80) <0.001/0.003 1.25 (1.03 to 1.51) 0.021/0.034 0.90 (0.77 to 1.07) 0.233/0.244
Age, sex, anxiety and depression 
plus AgeAccelGrim
0.72 (0.60 to 0.86) <0.001/0.003 1.21 (1.00 to 1.45) 0.048/0.074 0.90 (0.77 to 1.06) 0.225/0.240
All* 0.76 (0.64 to 0.91) 0.002/0.004 1.15 (0.96 to 1.39) 0.128/0.159 0.87 (0.74 to 1.03) 0.104/0.135
*Age, sex, AgeAccelGrim, educational attainment, social class, total number of chronic diseases, time taken to walk 6 metres, smoking status, frequency of alcohol consumption, HADS 
anxiety score, HADS depression score.
†pFDR is the p value corrected for multiple comparisons using the False Discovery Rate.
HADS, Hospital Anxiety and Depression Scale.
Table 4 HRs (95% CI) of risk of death from all causes according to standardised scores for attitudes to ageing at age 72 years, adjusted for brain- 
PAD and covariates (n=622)
Adjustments
Attitudes to ageing scales (per sd)
Physical change †p/pFdr Psychosocial loss †p/pFdr Psychological growth †p/pFdr
Age and sex 0.64 (0.53 to 0.77) <0.001/0.003 1.44 (1.21 to 1.70) <0.001/0.003 0.88 (0.73 to 1.06) 0.169/0.195
Age, sex and brain- PAD 0.65 (0.54 to 0.78) <0.001/0.003 1.42 (1.20 to 1.69) <0.001/0.003 0.89 (0.74 to 1.07) 0.217/0.235
Age, sex and education 0.65 (0.54 to 0.79) <0.001/0.003 1.41 (1.18 to 1.67) <0.001/0.003 0.84 (0.70 to 1.02) 0.076/0.106
As above plus brain- PAD 0.67 (0.56 to 0.81) <0.001/0.003 1.39 (1.17 to 1.66) <0.001/0.003 0.84 (0.70 to 1.02) 0.085/0.116
Age, sex, smoking and alcohol 0.66 (0.55 to 0.80) <0.001/0.003 1.36 (1.15 to 1.61) <0.001/0.003 0.88 (0.73 to 1.06) 0.165/0.194
Age, sex, smoking and alcohol plus brain- 
PAD
0.68 (0.56 to 0.81) <0.001/0.003 1.35 (1.14 to 1.60) 0.001/0.002 0.89 (0.74 to 1.06) 0.194/0.133
Age, sex, chronic disease and walking 
speed
0.69 (0.57 to 0.84) <0.001/0.003 1.34 (1.12 to 1.60) 0.001/0.002 0.87 (0.73 to 1.05) 0.140/0.168
Age, sex, chronic disease and walking 
speed plus brain- PAD
0.71 (0.58 to 0.86) <0.001/0.003 1.34 (1.12 to 1.60) 0.001/0.002 0.88 (0.73 to 1.06) 0.180/0.204
Age, sex, anxiety and depression 0.68 (0.56 to 0.82) <0.001/0.003 1.36 (1.11 to 1.67) 0.003/0.006 0.93 (0.77 to 1.13) 0.477/0.492
Age, sex, anxiety and depression plus 
brain- PAD
0.68 (0.56 to 0.82) <0.001/0.003 1.37 (1.12 to 1.67) 0.002/0.004 0.94 (0.78 to 1.13) 0.489/0.497
All* 0.76 (0.62 to 0.92) 0.006/0.011 1.27 (1.04 to 1.55) 0.020/0.033 0.88 (0.73 to 1.07) 0.196/0.216
*Age, sex, brain- PAD, educational attainment, total number of chronic diseases, time taken to walk 6 metres, smoking status, frequency of alcohol consumption, HADS anxiety score, HADS 
depression score.
†pFDR is the p value corrected for multiple comparisons using the False Discovery Rate.
Brain- PAD, brain- predicted age difference; HADS, Hospital Anxiety and Depression Scale.
attitude to psychological growth also had a lower risk of death 
in age- adjusted and sex- adjusted models: for an SD higher score, 
the HR was 0.87 (0.74 to 1.02), but this was not significant. 
Adjustment for AgeAccelGrim attenuated this by 15.4%.
In people with data on brain- PAD, the associations between 
attitudes to ageing and mortality were similar to those described 
above. In this sample, having a more positive attitude to phys-
ical change and to psychosocial loss were both associated with 
lower mortality and these associations remained significant after 
adjustment for all covariates after correction for multiple testing. 
However, the amount explained by brain- PAD was tiny: adjust-
ment for this attenuated the age- adjusted and sex- adjusted HRs 
between attitudes to physical change or psychosocial loss and 
mortality by 2.8% and 4.5%, respectively.
dIsCussIOn
In these older adults, having a more positive attitude to phys-
ical change was associated with being biologically younger 
as measured by AgeAccelGrim and brain- PAD in age- adjusted 
and sex- adjusted models. These associations were attenuated 
by adjustment for covariates, and neither was significant after 
adjustment for all covariates and correction for multiple testing. 
Attitudes to psychosocial loss or psychological growth were 
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What is already known on this subject
 ► Older people with more negative attitudes to ageing have an 
increased risk of adverse health outcomes, including earlier 
death.
 ► The underlying mechanisms are poorly understood. One 
possibility may be that people with more negative attitudes 
to ageing are biologically older.
What this study adds
 ► Older people with a more negative attitude to physical 
change were biologically older as defined by accelerated 
DNA methylation GrimAge and brain- predicted age 
difference in age- adjusted and sex- adjusted models.
 ► These associations were no longer significant after further 
adjustment for potential confounding or mediating variables 
and correction for multiple testing.
 ► Having a more positive attitude to physical change was 
associated with reduced risk of death, but biomarkers 
of ageing, and other covariates, explained little of this 
association.
not significantly associated with AgeAccelGrim or brain- PAD. 
None of the three attitudes to ageing domain scores were asso-
ciated with leucocyte telomere length. People with more posi-
tive attitude to physical change had a lower risk of death during 
follow- up; being biologically younger as measured by AgeAc-
celGrim and brain- PAD accounted for at most 14.7% or 2.8%, 
respectively of these relationships. Having a more positive atti-
tude to psychosocial loss was also associated with a lower risk of 
death, but only in the subsample with data on brain- PAD.
There is little prior evidence about the relationships between 
attitudes to ageing and ageing biomarkers. Contrary to the find-
ings here, one study found that positive attitudes to ageing were 
associated with having a longer telomere length 4 years later.15 
This study did not use a continuous measure of telomere length 
but created a binary indicator of whether telomere length was 
‘normal length’ or ‘shorter length’ and did not examine different 
attitude domains separately. To our knowledge, this is the first 
study to examine the associations between attitudes to ageing 
and brain- PAD and AgeAccelGrim. A recent study found that 
younger subjective age is associated with less- advanced brain 
ageing.16 This is consistent with our findings using a broader 
measure of attitudes of ageing.
Other studies which found associations between attitudes to 
ageing and mortality10 11 used the ‘Attitudes Toward Ageing’ 
subscale from Philadelphia Geriatric Center Morale Scale 
(PGCMS).33 These findings are consistent with the present study 
since there is considerable overlap between items in this scale 
and the physical change domain of the AAQ.1 Items from the 
PGCMS and the physical change domain of the AAQ tend to 
focus on personal experience of ageing (eg, “My health is better 
than I expected for my age”1), while items from the psychosocial 
loss and psychological growth AAQ domains focus on attitudes 
towards the ageing process more generally (eg, ‘Old age is a time 
of loneliness’1). To the best of our knowledge, this the first study 
to examine the role of biomarkers of ageing in explaining the 
relationship between attitudes to ageing and mortality.
This study has several strengths. The AAQ has been validated 
on samples of older people from several countries.34 35 A variety 
of potential confounding or mediating factors were controlled 
for. Statistics on variability of the biomarkers of ageing, either at 
wave 2 or over successive waves of data collection, show they are 
reliable measures. One major limitation is that the relationship 
between attitudes to ageing and ageing biomarkers was analysed 
cross- sectionally, making it impossible to determine the direc-
tion of relationships. It is important to note that although we 
included smoking as a covariate, DNA methylation- based surro-
gates for smoking are one of the components of DNA methyl-
ation GrimAge.27 Indeed, as smoking status is highly correlated 
with AgeAccelGrim (rho=0.484, p<0.001), adjustment for 
smoking complicates the interpretation of the relationship 
between AgeAccelGrim and attitudes to ageing. Although we 
took account of the number of diagnoses of chronic illnesses 
participants reported, no data were collected specifically on 
diagnoses of chronic obstructive pulmonary disease and we had 
no information on hospitalisations in the past year which might 
have provided an indicator of disease severity. The LBC1936 
cannot be considered representative of the general population 
of Scotland born in that year as they have continued to live in 
the Lothian area. They also had a higher mean childhood intelli-
gence than the overall population, and are likely to have higher 
educational attainment and more advantaged social class.
The association between attitudes towards physical change 
and mortality could reflect the fact that people who have poor 
health are both more likely to die and more likely to report 
physical decline on the AAQ. More advanced methylation ageing 
is manifest as impaired physical function36 and it can be assumed 
that negative attitudes towards physical change simply represent 
an awareness of this impaired function. However, the associa-
tion remained significant after controlling for chronic disease 
and walking speed. Levy argues that people’s attitudes to ageing 
are not a proxy for physical health but predict mortality by 
becoming a self- fulfilling prophecy.2 Indeed, previous research 
suggests that attitudes to ageing measured many years earlier 
predict health and longevity in older age.4 9 10 37
This study found limited evidence that attitudes to ageing are 
linked with ageing biomarkers. More positive attitudes towards 
physical change were associated with being biologically younger, 
as indicated by AgeAccelGrim and brain- PAD in age- adjusted 
and sex- adjusted models, but these associations were not signif-
icant after full adjustment for confounding or mediating factors 
and correction for multiple testing. Positive attitudes to phys-
ical change were associated with a reduced mortality risk after 
adjustment for confounding or mediating factors, but AgeAccel-
Grim or brain- PAD explained very little of this association. Since 
trials have shown that improving people’s attitudes to ageing 
benefits physical health and function,38–40 such initiatives may 
also decelerate biological ageing and reduce mortality. Further 
research should explore the longitudinal effects of attitudes to 
ageing on ageing biomarkers and examine whether other factors 
(eg, cardiovascular stress) explain the relationship between atti-
tudes to physical change and mortality.
Acknowledgements The authors would like to thank the LBC1936 study 
participants. The authors would also like to thank the LBC1936 team members and 
research nurses for collecting, collating and checking phenotypic data.
Contributors CG and ID planned the study; JC conducted the analyses that 
provided the brain age data; SH conducted the analyses that provided the telomere 
length data; RM conducted the analyses that provided the methylation age data; 
KMcL and CG carried out the statistical analysis; KMcL drafted the manuscript. 
All authors contributed to the interpretation of the data and critically revised the 
manuscript.
Funding This work was supported by the Disconnected Mind project (funded by 
Age UK and MRC (Mr/M01311/1 and G1001245/96077)) and undertaken within 
 o
n
 M
arch 30, 2020 by guest. Protected by copyright.
http://jech.bmj.com/
J Epidem
iol Com
m
unity Health: first published as 10.1136/jech-2019-213462 on 28 January 2020. Downloaded from 
383McLachlan KJJ, et al. J Epidemiol Community Health 2020;74:377–383. doi:10.1136/jech-2019-213462
Original research
the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology 
(funded by the BBSRC and MRC as part of the Life Long Health and Wellbeing 
programme (MR/K026992/1)).
Competing interests None declared.
Patient consent for publication Not required.
ethics approval Ethical approval was obtained from the Multicentre Ethics 
Committee for Scotland (MREC/01/0/56) and Lothian Research Ethics Committee 
(LREC/2003/2/29).
Provenance and peer review Not commissioned; externally peer reviewed.
data availability statement Data may be obtained from a third party and 
are not publicly available. Data are available only on request because there are 
ethical restrictions on openly sharing the dataset. The consent forms for the study 
included that participants’ data, some of which is sensitive, would only be used for 
research. Data are available by submitting a data access form to  i. deary@ ed. ac. uk or  
lbc1936@ ed. ac. uk.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
OrCId id
Catharine R Gale http:// orcid. org/ 0000- 0002- 3361- 8638
RefeRences
 1 Laidlaw K, Power MJ, Schmidt S, et al. The attitudes to ageing questionnaire (AAQ): 
development and psychometric properties. Int J Geriatr Psychiatry 2007;22:367–79.
 2 Levy B. Stereotype Embodiment: a psychosocial approach to aging. Curr Dir Psychol 
Sci 2009;18:332–6.
 3 Bryant C, Bei B, Gilson K, et al. The relationship between attitudes to aging and 
physical and mental health in older adults. Int Psychogeriatr 2012;24:1674–83.
 4 Levy BR, Zonderman AB, Slade MD, et al. Age stereotypes held earlier in life predict 
cardiovascular events in later life. Psychol Sci 2009;20:296–8.
 5 Stephan Y, Sutin AR, Terracciano A. Feeling older and risk of hospitalization: evidence 
from three longitudinal cohorts. Health Psychol 2016;35:634–7.
 6 Levy BR, Slade MD, Murphy TE, et al. Association between positive age stereotypes 
and recovery from disability in older persons. JAMA 2012;308:1972–3.
 7 Robertson DA, King- Kallimanis BL, Kenny RA. Negative perceptions of aging predict 
longitudinal decline in cognitive function. Psychol Aging 2016;31:71–81.
 8 Westerhof GJ, Miche M, Brothers AF, et al. The influence of subjective aging on health 
and longevity: a meta- analysis of longitudinal data. Psychol Aging 2014;29:793–802.
 9 Uotinen V, Rantanen T, Suutama T. Perceived age as a predictor of old age mortality: a 
13- year prospective study. Age Ageing 2005;34:368–72.
 10 Kotter- Grühn D, Kleinspehn- Ammerlahn A, Gerstorf D, et al. Self- perceptions of aging 
predict mortality and change with approaching death: 16- year longitudinal results 
from the Berlin aging study. Psychol Aging 2009;24:654–67.
 11 Sargent- Cox KA, Anstey KJ, Luszcz MA. Longitudinal change of self- perceptions of 
aging and mortality. J Gerontol B Psychol Sci Soc Sci 2014;69:168–73.
 12 Weiss D. On the inevitability of aging: Essentialist beliefs moderate the impact of 
negative age stereotypes on older adults’ memory performance and physiological 
reactivity. J Gerontol B Psychol Sci Soc Sci 2016;73:625–73.
 13 Levy BR, Moffat S, Resnick SM, et al. Buffer against cumulative stress. GeroPsych 
2016;29:141–6.
 14 Stephan Y, Sutin AR, Terracciano A. Younger subjective age is associated with lower 
C- reactive protein among older adults. Brain Behav Immun 2015;43:33–6.
 15 Pietrzak RH, Zhu Y, Slade MD, et al. Association between negative age stereotypes 
and accelerated cellular aging: evidence from two cohorts of older adults. J Am 
Geriatr Soc 2016;64:e228–30.
 16 Kwak S, Kim H, Chey J, et al. Feeling how old I am: subjective age is associated with 
estimated brain age. Front Aging Neurosci 2018;10:168.
 17 Cole JH, Marioni RE, Harris SE, et al. Brain age and other bodily ’ages’: implications 
for neuropsychiatry. Mol Psychiatry 2019;24:266–81.
 18 AT L, Quach A, Wilson JG, et al. Dna methylation GrimAge strongly predicts lifespan 
and healthspan. Aging 2019;11:303.
 19 Marioni RE, Harris SE, Shah S, et al. The epigenetic clock and telomere length are 
independently associated with chronological age and mortality. Int J Epidemiol 
2016;45:424–32.
 20 Cole JH, Ritchie SJ, Bastin ME, et al. Brain age predicts mortality. Mol Psychiatry 
2018;23:1385–92.
 21 Deary IJ, Whiteman MC, Starr JM, et al. The impact of childhood intelligence on later 
life: following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol 
2004;86:130–47.
 22 Taylor AM, Pattie A, Deary IJ. Cohort profile update: the Lothian birth cohorts of 1921 
and 1936. Int J Epidemiol 2018;47:1042–1042r.
 23 Harris SE, Marioni RE, Martin- Ruiz C, et al. Longitudinal telomere length shortening 
and cognitive and physical decline in later life: the Lothian birth cohorts 1936 and 
1921. Mech Ageing Dev 2016;154:43–8.
 24 Horvath S. Dna methylation age of human tissues and cell types. Genome Biol 
2013;14:R115.
 25 Hannum G, Guinney J, Zhao L, et al. Genome- Wide methylation profiles reveal 
quantitative views of human aging rates. Mol Cell 2013;49:359–67.
 26 Hillary RF, Stevenson AJ, Cox SR, et al. An epigenetic predictor of death captures 
multi- modal measures of brain health. bioRxiv 2019:703504.
 27 Marioni RE, Shah S, McRae AF, et al. Dna methylation age of blood predicts all- cause 
mortality in later life. Genome Biol 2015;16:25.
 28 Shah S, McRae AF, Marioni RE, et al. Genetic and environmental exposures 
constrain epigenetic drift over the human life course. Genome Res 
2014;24:1725–33.
 29 Wardlaw JM, Bastin ME, Valdés Hernández MC, et al. Brain aging, cognition in youth 
and old age and vascular disease in the Lothian birth cohort 1936: rationale, design 
and methodology of the imaging protocol. Int J Stroke 2011;6:547–59.
 30 Cole JH, Poudel RPK, Tsagkrasoulis D, et al. Predicting brain age with deep learning 
from raw imaging data results in a reliable and heritable biomarker. Neuroimage 
2017;163:115–24.
 31 Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr 
Scand 1983;67:361–70.
 32 Benjamini Y, Drai D, Elmer G, et al. Controlling the false discovery rate in behavior 
genetics research. Behav Brain Res 2001;125:279–84.
 33 Lawton MP. The Philadelphia geriatric center morale scale: a revision. J Gerontol 
1975;30:85–9.
 34 Kalfoss MH, Low G, Molzahn AE. Reliability and validity of the attitudes to ageing 
questionnaire for Canadian and Norwegian older adults. Scand J Caring Sci 
2010;24:75–85.
 35 Chachamovich E, Fleck MP, Trentini CM, et al. Development and validation of the 
Brazilian version of the attitudes to aging questionnaire (AAQ): an example of 
merging classical psychometric theory and the Rasch measurement model. Health 
Qual Life Outcomes 2008;6:5.
 36 Marioni RE, Shah S, McRae AF, et al. The epigenetic clock is correlated with 
physical and cognitive fitness in the Lothian birth cohort 1936. Int J Epidemiol 
2015;44:1388–96.
 37 Levy BR, Ferrucci L, Zonderman AB, et al. A culture–brain link: Negative age 
stereotypes predict Alzheimer’s disease biomarkers. Psychol Aging 2016;31:82–8.
 38 Brothers A, Diehl M. Feasibility and Efficacy of the AgingPlus Program: Changing Views 
on Aging to Increase Physical Activity. J Aging Phys Act 2017;25:402–11.
 39 Levy BR, Pilver C, Chung PH, et al. Subliminal strengthening. Psychol Sci 
2014;25:2127–35.
 40 Wolff JK, Warner LM, Ziegelmann JP, et al. What do targeting positive views on ageing 
add to a physical activity intervention in older adults? results from a randomised 
controlled trial. Psychol Health 2014;29:915–32.
 o
n
 M
arch 30, 2020 by guest. Protected by copyright.
http://jech.bmj.com/
J Epidem
iol Com
m
unity Health: first published as 10.1136/jech-2019-213462 on 28 January 2020. Downloaded from 
